by Brooks | Jul 1, 2025 | News, Precision Health Personalized Medicine, Reduce Adverse Drug Reactions, Research PGx
for immediate release July 1, 2025 07:00 a.m. Pacific Standard Time & 8:00 a.m. Mountain Standard Time TUCSON, A.Z. – UGenome AI, a pioneer in genomic platforms to fuel personalized medicine, today announced a strategic partnership with Genetic Lifehacks to...
by Brooks | Jun 3, 2025 | Digital Twin-in silico, News, Precision Health Personalized Medicine, Reduce Adverse Drug Reactions, Research PGx
On May 7, 2025 UGenome AI’s Founder & CEO Zachary S. Brooks, PhD, EMBA gave a talk at University of Liverpool on “PGx & Digital Twins” supported by Wahbi El-Bouri, Senior Lecturer, Digital Twins and In Silico Clinical Trials. Thank you...
by Brooks | Jun 2, 2025 | News, Precision Health Personalized Medicine, Research PGx
On April 28, 2025, UGenome AI team mates Ayse ULGEN, PhD, MGM, Peter Bannister, and Zachary S. Brooks, PhD, EMBA gave a talk to Nottingham Trent University entitled: “UGenome AI’s promise to revolutionize the pharmacogenomics research –...
by Brooks | Dec 29, 2024 | Emerging Trends, Research PGx
Jayden Lee, EMBA, PharmD, BCACP and Husna Rahim, PharmD Ethical Challenges in Pharmacogenomics Research. What are some key ethical issues in healthcare today? As the integration of genomic data into healthcare decisions becomes more widespread, it is vital to examine...
